Troy Moore is the chief scientific officer at Kailos Genetics. Troy has more than 17 years experience in the development of biotechnology companies. He was a co-founder of Open Biosystems in 2002 where he served as the Chief Technology Officer until the company was acquired by ThermoFisher Scientific. As the company's CTO, Troy was responsible for the development of new products, technology licensing, and collaborative research.

Troy Moore
ADDitude’s Editorial and Medical Review Process
ADDitude is dedicated to publishing quality content that adheres to the highest scientific and editorial standards. Created by qualified writers and medical professionals, our content is fact-checked and reviewed by members of the ADDitude Medical Advisory Panel, including leading clinical practitioners and researchers within the field of ADHD. The ADDitude team adheres to strict editorial standards and journalistic principles. Health information and guidance is thoroughly researched, and sources are vetted to ensure recency, authority, and credibility.
ADDitude editors regularly revisit and update existing content for accuracy and reliability, often in coordination with ADDitude’s Medical Advisory Panel and according to the ADDitude Editorial Process.